Enabling the expansion of a US biotech by placing a pivotal QA senior leadership hire

How we overcame location and expertise challenges to secure a key leadership role in clinical quality assurance.

1
Critical senior appointment
9
Days to present the hired candidate

Scholar Rock, a mid-sized biotech firm, was facing a critical need to expand its quality department by hiring an Associate Director of Clinical Quality Assurance. Despite a month-long search by their internal talent team, the role remained unfilled, highlighting the challenge of finding a candidate with the required GCP expertise, leadership ability, and willingness to work onsite in Cambridge, MA.

Problems identified

Scholar Rock required an Associate Director of Clinical Quality Assurance with a specialized GCP background and the confidence to lead a team with minimal additional training. The role's location in Cambridge, MA, and its seniority made it difficult to find candidates willing to relocate or manage a long commute. The position was crucial as it would serve as the foundation for building out a junior QA team.

 

What was at stake

Without securing the right candidate, Scholar Rock risked delays in expanding their quality department, potentially hindering the overall growth and operational efficiency of the organization.

Results

The hired candidate for the Director of Clinical Quality Assurance position was presented to Scholar Rock within nine working days, enabling Scholar Rock to move forward with their broader quality department expansion.

Impact

This strategic hire provided the leadership necessary to guide the team effectively, allowing Scholar Rock to continue its growth trajectory and maintain its commitment to quality assurance in clinical development.

Build your own success story.

Allow us to support with your hiring requirements and scale as Scholar Rock did. Get in touch with details about your current talent needs and let's build a winning strategy together.

Explore similar projects.

We began working with Ablative after a major funding round, where they had their initial sights set on the launch of their clinical program within Europe and required staff across 8 sites.

Read More

With fast-tracked designation for their lead product, AveXis required highly-skilled candidates with expertise in neuroscience and orphan diseases to lead their product to commercialization.

Read More

RVAC Medicines, a biotech firm specializing in mRNA technology, was embarking on an exciting journey to launch a new R&D facility in Boston—a previously unknown territory to them.

Read More
Copyright © All Rights Reserved SEC Life Sciences
Site by Venn